Dual inhibition of intercellular adhesion molecule-1 and nucleolin reduces RSV infection efficiency in human respiratory organoids
Authors:
Open Access
- 17 April 2026
- journal article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 37 (2) , 102932
Abstract
No abstract availableKeywords
Funding Information
- Japan Science and Technology Agency
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
This publication has 32 references indexed in Scilit:
- Hospitalization Following Outpatient Diagnosis of Respiratory Syncytial Virus in AdultsJAMA Network Open, 2024
- Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant dataThe Lancet, 2024
- Virological characteristics of the SARS-CoV-2 BA.2.86 variantCell Host & Microbe, 2024
- ‘A good day’: FDA approves world’s first RSV vaccineNature, 2023
- Evaluation of Broad Anti-Coronavirus Activity of Autophagy-Related Compounds Using Human Airway OrganoidsMolecular Pharmaceutics, 2023
- Epidermal growth factor receptor in asthma: A promising therapeutic target?Respiratory Medicine, 2023
- Essential roles of insulin and IGF-1 receptors during embryonic lineage developmentMolecular Metabolism, 2021
- Identification of nucleolin as a cellular receptor for human respiratory syncytial virusNature Medicine, 2011
- Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cellsMicrobes and Infection, 2003
- Blocking Intercellular Adhesion Molecule-1 on Human Epithelial Cells Decreases Respiratory Syncytial Virus InfectionBiochemical and Biophysical Research Communications, 2001